<DOC>
	<DOCNO>NCT02610621</DOCNO>
	<brief_summary>Eligible patient female , age 18 old diagnosis Clinical T1 T2 invasive breast cancer suspicious palpable adenopathy . Patients undergo standard care lumpectomy without sentinel node biopsy whole breast radiation , follow chemotherapy . Sentinel node biopsy also consider standard care patient localize breast cancer . Treatment often influence whether result biopsy show cancer . However , biologic factor primary tumor become important determine treatment recommendation woman clinically node negative breast cancer .</brief_summary>
	<brief_title>Safety Efficacy Sentinel Node Biopsy Omission Breast Cancer Patients Who Plan Have Adjuvant Chemotherapy</brief_title>
	<detailed_description>The primary objective study determine locoregional recurrence rate patient clinically node negative T1 T2 breast cancer treat systemic chemotherapy whole breast irradiation biopsy sentinel node perform . A locoregional recurrence define recurrence ipsilateral axillary node supraclavicular node . After surgery , patient receive standard care radiation affect breast chemotherapy . A physical examination affect breast regional lymph node conduct every six month first two year follow yearly last 3 year follow . Imaging affect breast occur every 12 month surgery per standard care .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Female age 18 old , pregnant lactate Clinical T1 T2 invasive cancer suspicious palpable adenopathy If abnormal axillary node see preoperative imaging , negative fine needle aspiration core biopsy require study entry . Planned treatment breast conserving surgery whole breast irradiation Chemotherapy require postoperatively base patient tumor characteristic diagnosis Patients suspicious palpable axillary adenopathy Patients biopsy demonstrate axillary nodal metastases Patients treatment mastectomy Patients undergone neoadjuvant chemotherapy Patients comorbidities render patient candidate chemotherapy , surgery , irradiation Patients treat accelerated partial breast irradiation ( APBI ) Patients contraindication radiation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Clinically node negative</keyword>
	<keyword>T1 T2 invasive breast cancer</keyword>
</DOC>